The study from Tulane University found that those living in once-redlined neighborhoods see 15% longer delays in achieving successful viral suppression of HIV compared to those in non-redlined areas.
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets USP, 600 mg are indicated ...
Shanghai Daily on MSN3d
Patients to benefit from major CIIE purchasesCity-level hospitals purchase 14 large medical appliances, all from leading international companies, at the CIIE on Friday alongside cooperation on infectious disease management.
Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...
Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its ...
Babies getting HIV from their infected mothers is a rare occurrence in a cluster of 39 villages in the OR Tambo District in ...
The National HIV and AIDS Control Programme of the Ghana Health Service (GHS) has reported over 34,000 new HIV infections ...
The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.
Johnson & Johnson announced that the China National Medical Products Administration has approved Teclistamab Injection as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback